Navigation Links
CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase
Date:10/9/2008

) Statement

Except for historical and factual information contained herein, this press release contains forward-looking statements, such as revenue growth rates and cash flow projections, operating performance and acceptance of ICG technology, the accuracy of which is necessarily subject to uncertainties and risks, including the Company's ability to meet its short and long-term liquidity and capital needs, primary dependence on the BioZ(R) product line, and various uncertainties characteristic of early stage companies, as well as other risks detailed in the Company's filings with the SEC, including its 2007 Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Future events and actual results could differ materially from the forward-looking statements. Readers are urged not to place undue reliance on forward-looking statements. The Company does not undertake to update the disclosures contained in this press release.

CardioDynamics International Corporation

In thousands, except per share data (unaudited)

Selected Consolidated Operational Three Months Nine Months

Results Ended Ended

August 31, August 31,

2008 2007 2008 2007

Net sales $6,066 $5,591 $18,008 $15,699

Cost of sales 1,519 1,554 5,066 4,740

Gross margin 4,547 4,037 12,942 10,959

Research and development 386 420 1,070 1,317

Selling and marketing 3,669 3,977 11,112 11,101

General and administrative 714 772 2,246 2,437

Amortization of intangible assets 32 30 96 115

Loss from operations (2
'/>"/>

SOURCE CardioDynamics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. CardioDynamics BioZ(R) ICG Technology Integrates with General Electric Healthcares Centricity(R) Electronic Medical Record (EMR) System
2. CardioDynamics Shareholders Approve One-for-Seven Reverse Split of Companys Common Stock and Trading in Post-split Shares Begins May 9, 2008
3. CardioDynamics Receives Nasdaq Letter of Non-Compliance With Minimum Bid Price Requirement
4. CardioDynamics BioZ(R) ICG Technology Featured in American College of Cardiology (ACC) Audio Series
5. CardioDynamics Ranked in Deloittes Technology Fast 50 Program for San Diego
6. CardioDynamics Receives FDA 510(k) Clearance for Innovative Clinical Parameters and Electronic Medical Record Compatibility
7. CardioDynamics Provides 2007 Shareholder Meeting Update
8. Paper in Cell Cycle Reports Alfacells ONCONASE(R) Targets siRNA
9. Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics
10. TorreyPines Therapeutics Reports Successful End-of-Phase II Meeting With FDA for Tezampanel
11. Corgenix Reports Fiscal 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Pa. , July 28, 2015 ... and Drug Administration has accepted for review the company,s ... factor VIII single-chain (rVIII-SingleChain) for the treatment of hemophilia ... primary endpoints. Hemophilia A ... defective factor VIII; nearly all affected patients are male. ...
(Date:7/27/2015)...  Amgen (NASDAQ: AMGN ) today announced that ... Thursday, July 30, 2015, after the close of the ... a conference call with the investment community at 2 ... be Robert A. Bradway , chairman and chief ... team. Live audio of the conference call ...
(Date:7/27/2015)... ... July 27, 2015 , ... ... today announced a new video: 3 Ways to GHS Labels . This ... and the Globally Harmonized System (GHS) by effectively labeling chemical containers. , “With ...
(Date:7/27/2015)... 27, 2015 The Brain & ... of its annual Klerman and Freedman Prizes, recognizing ... have been supported by NARSAD Young Investigator Grants. ... innovative ideas in neurobiological and psychosocial research, garner ... the early detection, treatment, prevention and cure of ...
Breaking Biology Technology:U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 3Amgen Announces Webcast of 2015 Second Quarter Financial Results 2Brady Releases “3 Roads to GHS Labels” Video 2Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 2Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 3Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 4Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 5Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 6
... Inc., a biotechnology corporation working on innovations for humane ... Siegel as Vice President of Business Development. , ... experience in executive management positions. He has served ... Information Technology Group, Inc., Director of ILINC Communications, Inc., ...
... from an alga so that it resembles the extremely efficient ... determine the structure of these light antennae. This is the ... leaf. The researchers will be publishing an article on their ... PNAS journal in the week starting 29 June. Leiden ...
... PROMOTIONAL SYSTEMS, INC. (Pink Sheets: VGPR) today announced it has ... to assist the Company in building a biomass production facility ... its intention to build a biomass plant in Georgia to ... State,s Bioenergy Corridor. Georgia ranks third in the nation ...
Cached Biology Technology:SenesTech Announces New Vice President of Business Development 2First step to converting solar energy using 'artificial leaf' 2Vega Picks Tennessee Firm to Assist with Construction of Biomass Plant in Georgia 2
(Date:7/8/2015)... YORK , July 8, 2015 Summary ... globally, and the fourth most fatal, with a mortality ... The poor prognosis of pancreatic cancer patients has highlighted ... treatment, which is not being met by the current ... an array of products with varying molecule types and ...
(Date:7/8/2015)... 8, 2015 The consumer products industry ... must have products such as wearables, smart wallets & other ... biometrics based devices continues to rapidly grow.  Biometrics & Wearable ... NXTD ), Google Inc. (NASDAQ: GOOG ), Apple Inc. ... GoPro, Inc. (NASDAQ: GPRO ) and Baidu Inc. (NASDAQ: ...
(Date:7/7/2015)... July 7, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... growing mobile commerce market announces a revised version of one of ... commercial will air on CNBC in New York ... and San Francisco metro areas.    ... on Wocket,s ability to replace all the cards in your wallet ...
Breaking Biology News(10 mins):Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 2Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 3Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 4Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 5Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 6Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3
... (Land-use intensity and Ecological Engineering Assessment ... based production systems) is organizing a conference, entitled ... which will be held in Banaue, The Philippines ... 21 research institutions from Germany, Vietnam, The Philippines, ...
... Germany: The first report of the diagnostic use of the ... analysed, shows that it can give good results at low cost, ... of the European Society of Human Genetics today (Monday). ... around 20% of 100 cases of patients with intellectual disability (ID) ...
... Nature Medicine shows that boosting a protein ... from otherwise fatal radiation poisoning. Scientists in the ... June 24 say their findings open the potential ... or environmental exposures such as in a nuclear ...
Cached Biology News:Exome sequencing gives cheaper, faster diagnosis in heterogeneous disease 2Exome sequencing gives cheaper, faster diagnosis in heterogeneous disease 3Boosting blood system protein complex protects against radiation toxicity 2Boosting blood system protein complex protects against radiation toxicity 3
... a cocktail of 3 siRNAs specifically targeted ... most popular product. The siTrio reagent guarantees ... your target gene when used under standard ... confirmation of optimal transfection with one of ...
... 25-Hydroxy Vitamin D kit is an ... of 25-hydroxyvitamin D (25-OH D) and ... or plasma. Our patented DIRECT assay ... precipitation and centrifugation and therefore facilitates ...
... The IDS EIA kit is a complete ... Vitamin D (1,25D) in human serum or ... immunoextraction system found in the IDS 1,25D ... The assay comes with ready to use ...
Rabbit polyclonal to Nck alpha ( Abpromise for all tested applications). entrezGeneID: 4690 SwissProtID: P16333...
Biology Products: